Virginia Boldt AstraZeneca

Virginia Boldt is an Associate Director Supply Chain at AstraZeneca supporting radiopharmaceuticals. Boldt joined AstraZeneca as part of an acquisition of Fusion Pharmaceuticals, where Boldt managed isotope vendors and several supply chain digitialization initiatives. Previously, Boldt worked in management consulting at Accenture and has experience with cold chain distribution and shopfloor improvement projects, and she has supported initiatives to drive innovations in the Life Sciences industry. Prior to Accenture, Boldt worked at Merck’s vaccine manufacturing plant located in Pennsylvania. Boldt spent the majority of her tenure at Merck in Technical Operations, leading change control on a projects team supporting an E2E of several sterile liquid vaccines. Boldt also supported the Capital Projects organization at Merck, implementing lean manufacturing tools and techniques. Lastly, Boldt has a Bachelor of Science in Operations Research engineering from Cornell University.